ARTISS Frozen is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Baxalta Us Inc.. The primary component is Fibrinogen Human; Human Thrombin.
| Product ID | 0944-8503_183b59f6-1e19-4a35-86f2-b2e77fdb2709 |
| NDC | 0944-8503 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ARTISS Frozen |
| Generic Name | Fibrinogen Human Thrombin Human |
| Dosage Form | Solution |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2011-01-11 |
| Marketing End Date | 2019-06-30 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125266 |
| Labeler Name | Baxalta US Inc. |
| Substance Name | FIBRINOGEN HUMAN; HUMAN THROMBIN |
| Active Ingredient Strength | 90 mg/mL; [iU]/mL |
| Pharm Classes | Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [CS],Human Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Blood Coagulation Factors [CS] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2011-01-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA125266 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2008-03-08 |
| Marketing End Date | 2019-07-31 |
| Marketing Category | BLA |
| Application Number | BLA125266 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2011-01-11 |
| Marketing End Date | 2019-06-30 |
| Marketing Category | BLA |
| Application Number | BLA125266 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2009-03-19 |
| Marketing End Date | 2019-06-30 |
| Ingredient | Strength |
|---|---|
| FIBRINOGEN HUMAN | 90 mg/mL |
| SPL SET ID: | 13f76667-ec2f-4fa7-a9e8-12502d8224db |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ARTISS 78514937 3502970 Live/Registered |
Baxter International Inc. 2004-11-10 |